MedTrace Logo

E-Polycaprolactone-Containing Membrane in Alveolar Bone Regeneration

NCT06627621 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2024-10-04

No results posted yet for this study

Summary

This study aimed to evaluate the effectiveness of synthetic polycaprolactone (PCL) bioscaffold membranes used for alveolar augmentation in maxillofacial surgery for increasing the amount of newly formed bone after three-dimensional application.

Conditions

  • Alveolar Bone Grafting

Interventions

PROCEDURE

Alveolar Ridge Reconstruction

scaffold guided alveolar bone regeneration

Sponsors & Collaborators

  • cem üngör

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Months
Max Age
80 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2023-01-08
Completion
2023-01-08

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627621 on ClinicalTrials.gov